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This one-generation study assessed the potential of esteriﬁed propoxylated glycerol (EPG) to affect repro-
duction and offspring development in rats. Male and female Crl:CD(SD)BR rats (30/sex/group) were
exposed to EPG at 0, 0.5, 1, and 2 g/kg bw/day or at 5% (w/w) in the diet prior to (13 weeks), during,
and after two consecutive matings. For dams, exposure continued through gestation and lactation; F1a
and F1b pups were weaned to the respective diet (for up to 91 days). No consistent treatment-related
effects were observed in: body weights/gains; feed consumption; clinical observations; mating indices;
survival, growth and development of litters, litter sizes, body weights, sex ratios (lower % males/litter
at 1 and 2 g/kg bw/day), acquisition of developmental landmarks, behavioral indices, or histology of
selected organs. Lower serum vitamin D, liver vitamin A, and liver vitamin E levels were seen in some
EPG-treated groups. None of the reductions were judged to be biologically signiﬁcant. A/G ratio was
greater among males receiving 2 g/kg bw/day and 5%. In the absence of any other related effects, the
biological signiﬁcance of this ﬁnding is doubtful.
 2014 Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/3.0/).1. Introduction (RTI), Research Triangle Park, North Carolina, from September 24,Esteriﬁed propoxylated glycerols (EPGs) represent a family of
modiﬁed fat- and oil-like products, resembling triglycerides in
structure and appearance, but modiﬁed to prevent or limit their
digestion when consumed in food. They consist of multiple propyl-
ene glycol units inserted between the glycerol and fatty acid
moieties of fats and oils. Their poor absorption results in a low- to
no-calorie proﬁle when substituted for fat in the diet.
A one-generation reproduction study was performed in
Crl:CD(SD)BR rats to evaluate the potential of a version of EPG that
is considered the ‘‘core’’ version (H-EPG-05 HR/SO 9:1) to elicit
alterations in reproductive ability, including effects during lacta-
tion, growth and development of the offspring. Vitamin status
and neurobehavioral parameters were also evaluated.
2. Materials and methods
This study was sponsored by ARCO Chemical Company, Newton
Square, Pennsylvania, and conducted at Research Triangle Institute1992 to August 10, 1993, in compliance with the Principles of Good
Laboratory Practice (GLP) regulations, of the United States Food
and Drug Administration (FDA).2.1. Animals
Sprague-Dawley-derived outbred albino (Crl:CD(SD)BR rats
(age: 28 days) were obtained from Charles River Laboratories,
Inc. (Raleigh, NC) and allowed to acclimate to the laboratory envi-
ronment for approximately 2 weeks before exposure to the test
diets. At the end of the acclimation period, animals were stratiﬁed
based on body weight and allocated randomly within weight clas-
ses, to ﬁve treatment groups, each consisting of 30 animals per sex
per group.2.2. Mating
Thirty (30) animals/sex/group assigned were designated as F0
parental animals. One male to one female from each group was
selected at random and housed together continuously for up to
21 days until insemination of the female was conﬁrmed. Females
presumed pregnant were observed twice daily during gestation
for evidence of littering. The ﬁrst litters were designated as F1a.
The F0 females were allowed to rear their young to postnatal day
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weaned. As the last F1a litter was weaned, F0 females were allowed
to rest for at least 10 days before a second mating with different
males within the same treatment group. The second mating
followed the same procedure; litters from this mating were
designated as F1b.
2.3. Satellite animals
Prior to weaning of the ﬁrst F1a and F1b litters, ten (10) litters
per dose group were randomly selected to create satellite groups,
A, B, and C. Group A and B pups were sacriﬁced on PND 21 and
PND 49, respectively, and subjected to necropsy, clinical pathology,
vitamin status and tissue EPG. Group C pups were sacriﬁced on
PND 91 and subjected to these procedures and to motor activity
and functional observational battery on PNDs 21, 42, 63, and 84.
2.4. Housing
F0 females were housed individually in solid bottom polycar-
bonate cages with stainless steel wire lids, except during mating,
when each cage held one male and one female; females were
housed individually during gestation and after littering until litters
were weaned (PND 21). Individual weanlings were housed singly.
Environmental controls for the animal room were set to maintain
68–75 F, a relative humidity of 40–70%, and a 12-hour light/12-
hour dark cycle. Variations from these conditions were docu-
mented and none were considered to have any effect on the out-
come of the study. Food and water were provided ad libitum.
There were no known contaminants in the food or water that
would have interfered with this study.
2.5. Test material
The test material, esteriﬁed propoxylated glycerol [H-EPG HR/
SO 9:1; EPG (stabilized with tocopherols, including a-tocopherol),
lot # 753489], was provided by the sponsor. The test article was a
white-colored, odorless solid received and stored frozen
(20 ± 5 C) in the original containers at RTI.
The vehicle, Mazola corn oil, was received from Best Foods, a
Division of CPC international, Inc. 1120 Commerce Avenue, Union,
NJ 07083. According to the supplier, all cases came from the same
lot (Lot No. 2321) of material. The vehicle was received and stored
frozen (20 ± 5 C). The characterization data were provided by
the supplier (100% total fatty acids by GC analysis as methyl esters)
and the purity was assumed to be 100% for the purpose of concen-
tration calculations.
The carrier was Modifed NIH-07 Certiﬁed Mouse/Rat Diet No.
7722 [omitting soy oil (2.5%), decreasing corn oil by 3.5%, and factor-
ing each ingredient level by 0.94 to allow for the addition of 6% corn
oil] manufactured by Harlan Teklad Permier Lab Diets (Madison,
WI), milled in Winﬁeld, IA. The feed was stored in temperature-
and humidity-regulated rooms (18 C; 50% relative humidity).
2.6. Feed formulation
Test diets were formulated weekly in a 2-ft3 V-shell blender
with an intensiﬁer bar (Patterson-Kelley Co., East Stroudsburg,
PA). Corn oil was used as is for the control feed; EPG was blended
with corn oil (40–60 C, 20 min) at the appropriate levels and the
mixture was combined with the basic feed for 0.75 to 1.25 h,
depending on the size of the batch.
Samples collected showed that the feed was homogeneous and
stable for at least 30 days when refrigerated (1–7 C) and for
49 days when frozen (12 to 18 C). Formulations were also sta-
ble under ambient conditions (in a feed jar in a cage; exposed toair, normal room lighting, and temperatures of 22–26 C) for at
least 9 days.
2.7. Dietary level selection and study design
EPG was incorporated in the diet at levels providing 0 (vehicle
control), 0.5, 1, or 2 g/kg bw/day; one group received EPG at a con-
stant level of 5% (w/w) in the feed. The dietary concentration of 5%
EPG was consistent with what is generally considered the maxi-
mum that can be given to animals without interfering with their
nutrition status and caloric needs. Other EPG dose levels were
administered on a g/kg bw/day/day basis to achieve constant expo-
sure levels throughout the study. During the last week of lactation,
females with litters were exposed to one-half of the target dietary
EPG level to prevent potential overdosing of self-feeding pups.
After weaning of their litters, F0 females went back to the target
EPG dietary levels until necropsy. F0 males were maintained on
the target EPG dietary level until necropsy. Litters were weaned
(PND 21) to the respective parental diet, adjusted based on body
weight.
2.8. Mortality and clinical signs
Cage-side observations for mortality and general condition
were made twice daily (morning and afternoon). Any animal
judged to be in moribund condition was euthanized by carbon
dioxide asphyxiation and then necropsied. Any animal found dead
was subjected to a complete gross pathological examination. Cage-
side observations included examination for general condition,
appearance, behavior, movement within the cage, availability of
feed and water, presence of excreta, and appearance and consis-
tency of the stools. Pregnant animals were examined for dystocia
(difﬁculty in delivery); any dam showing signs of imminent abor-
tion or premature delivery was sacriﬁced on the day such signs
were observed. Any abnormality in nesting and nursing behaviors
of the dams was recorded.
Detailed clinical examinations were conducted daily. Observa-
tions included, but were not limited to, changes in: skin and fur,
eyes and mucous membranes, excretion, respiratory system,
circulatory system, autonomic and central nervous system,
somatomotor activity, and behavior pattern.
2.9. Body weights, feed consumption, and EPG intake
F0 male body weights were determined and recorded at initia-
tion of treatment and weekly thereafter until scheduled sacriﬁce;
F0 female body weights were recorded in the same manner except
as follows. During gestation, females were weighed on gestational
days (GD) 0, 7, 14, and 20. Dams producing litters were weighed on
lactational days (PND) 0, 4, 7, 14, and 21. For non-pregnant females
showing either no signs of mating or signs of mating but no litters,
and for pregnant females with all dead pups on PND 0 or with com-
plete loss of the litter during lactation, body weights were recorded
at least weekly until scheduled sacriﬁce. Individual body weights
of live pups were measured at the time of parturition (PND 0)
and were recorded for days PND 4, 7, 14 and at weaning (PND
21). All animals were weighed at sacriﬁce. Individual body weight
gains were computed.
Feed consumption was recorded weekly for all F0 parental ani-
mals throughout the pre-mating treatment periods until cohabita-
tion of the sexes. For the male rats, weekly measurement of feed
consumption was resumed on the Monday following the return
to individual housing. During pregnancy, feed consumption of
the F0 females was recorded for GD 0–7, 7–14 and 14–20. During
lactation of the F1a and F1b litters, maternal feed consumption
was measured for PND 0–4, 4–7, and 7–14. Weekly measurement
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following weaning of the litters. Feed consumption was not mea-
sured for F0 males and F0 females during the cohabitation period,
since two adult animals (breeding pair) were in the same cage,
or for F0 females during the last week of the lactation periods
(PND 14–21) for F1a and F1b litters, since maternal feed consump-
tion after PND 14 was confounded by the contribution from the
pups, which were self-feeding by this time, and the concentration
of EPG in the diet for each adjusted group was reduced to 50% of its
previous level to prevent inadvertent overexposure of pups at this
time when they were self-feeding (as well as nursing) and ingest-
ing more feed (and therefore EPG) relative to their body weights,
than the adult animals. Upon weaning, feed consumption was
recorded weekly until scheduled sacriﬁce for the satellite group B
and C pups.
EPG intakes at the different time periods were calculated based
on feed consumption, EPG concentration in the diet, and body
weights.2.10. Reproductive and offspring parameters
Reproductive and offspring indices were calculated as shown in
Table 1. F1 pups were counted, sexed, weighed, and examined
grossly at birth (designated PND 0). The pups were recounted
and examined grossly on PND 4 (pre-culling), 7, 14, and 21 (wean-
ing). Anogenital distance was utilized as the method of sexing the
pups on PND 0–4; anogenital distance, presence/absence of fur
between anus and genital papilla, and shape of the scrotal area (ﬂat
or convex) was the method of sexing animals after PND 4.2.11. Hematology and clinical chemistry
Blood from the retro-orbital sinus was collected from all F0 ani-
mals immediately before initiation of treatment, before the ﬁrst
mating, and at the time of scheduled sacriﬁce. Blood from F1a
and F1b satellite groups was collected via cardiac puncture imme-
diately prior to sacriﬁce. The following parameters were measured:
nucleated red blood cells; corrected white blood cells; white blood
cell differential (segmented neutrophil, band neutrophil, lympho-
cyte, monocyte, eosinophil) counts; total protein; albumin; albu-
min:globulin (A/G) ratio; platelets; prothrombin time (PT); and
activated partial prothrombin time (APTT). If not enough blood
was available from a given animal (especially 21-day old F1Table 1
Methods used to calculate reproductive and offspring indices.
Index Calculation
Female fertility index (%) No. females pregnant/No. females
that mated  100
Male fertility index (%) No. males siring litters/No. males
that mated  100
Gestational index No. of females with live litters/
No. of females pregnant
Pregnancy index (%) No. pregnant females/No. males
that mated  100
Live birth index No. of live pups at birth/
Total No. of pups born
4-Day survival index No. of pups surviving 4 days (precull)/
Total No. of live pups at birth
7-Day survival index No. of pups surviving 7 days/
Total No. of live pups at 4 days (postcull)
14-Day survival index No. of pups surviving 14 days/
Total No. of live pups at 7 days
21-Day survival index No. of pups surviving 21 days/
Total No. of live pups at 14 days
Lactational index No. of pups surviving 21 days/
Total No. of live pups at 4 days (postcull)satellite group A pups) to measure all of the above parameters,
then only total and differential leukocyte counts were measured.
2.12. Developmental landmarks
The average day of acquisition for pre-selected developmental
landmarks was determined as follows. For pinna detachment, all
F1a and F1b pups were examined on PND 1–5, with expected acqui-
sition on PND 2–4; for lower incisor eruption, all F1a and F1b pups
were examined on PND 8–16, with expected acquisition on PND 9–
15; for auditory startle, all F1a and F1b pups were examined on PND
8–15, with expected acquisition on PND 10–14; for eye opening, all
F1a and F1b pups were examined on PND 11–18, with expected
acquisition on PND 12–17. For testis descent, all F1a and F1b males
were examined on PND 17–21; after weaning on PND 21, testis
descent was evaluated on F1a(C) and F1b(C) male pups only, with
expected acquisition on PND 17–30. For vaginal patency (opening),
all F1a(C) and F1b(C) females were examined on PND 28–43, with
expected acquisition on PND 30–38. For preputial separation, all
F1a(C) and F1b(C) males were examined on PND 30–50, with
expected acquisition on PND 30–35. The actual end dates for all
of the examinations were dependent on last date of acquisition
of the speciﬁc developmental landmark for the population evalu-
ated, but did not exceed the postnatal day listed above.
2.13. Functional observational battery and motor activity
A functional observational battery (FOB) test was conducted on
all F0 animals before study start and during the week before the
ﬁrst mating. The speciﬁc endpoints evaluated in the FOB are out-
lined in Table 2.
In addition, an assessment of motor activity using computer-
controlled ﬁgure-eight mazes (software from San Diego Instru-
ments, Inc., San Diego, CA) was conducted on F0 animals during
the week prior to the ﬁrst mating. A test session consisted of a con-
tinuous one-hour period, divided into twelve 5-min data-collection
segments. A predetermined distribution scheme was used to coun-
ter-balance animals by group across time and recording devices for
the motor activity test.
The FOB and motor activity assessments were also conducted
on F1a(C) and F1b(C) pups (as described above), on PND 21 ± 2
(weaning), PND 42 ± 2, PND 63 ± 2, and PND 84 ± 2.
2.14. Necropsy and histopathology
Parental animals and offspring on PND 21 through 91 were
weighed and then sacriﬁced by carbon dioxide asphyxiation; off-
spring on PND 4 were euthanized by decapitation. All animals in
all groups were subjected to a complete necropsy that includedTable 2
Functional observational battery (FOB) parameters measured.
Home cage Posture, tremors [exertion/resting], convulsions [clonic/
tonic], abnormal motor movements [writhing/circling/
bizarre], gait, gait score, and wasting
Handling Ease of removal, ease of handling, salivation,
piloerection, muscle tone, fur appearance, mouth and
nose deposits, and eyes [exophthalmus/deposits/
conjunctivitis/exudates/opacity/lacrimation]
Open ﬁeld Posture, tremors [exertion/resting], convulsions [clonic/
tonic], abnormal motor movements [writhing/circling/
bizarre], gait, gait score, vocalizations, arousal, urination
[No. spots], urination character, defecation [No. boli],
and defecation character
Sensory and
neuromuscular
Body weight, approach response, tail pinch response,
pupil response, hindlimb foot splay, forelimb grip
strength, hindlimb grip strength, and startle response
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cranial cavity; carcass; external and cut surfaces of the brain and
spinal cord; thoracic, abdominal, and pelvic cavities and their vis-
cera; and cervical tissues and organs. Special attention was paid to
examination of the reproductive organs.
Tissues/organs collected for histopathological examination
were preserved in 10% phosphate-buffered formalin, embedded
in parafﬁn, sectioned, stained with hematoxylin and eosin, and
examined microscopically. For F0 animals (control and 5% EPG
groups), tissues examined included vagina, testes, corpus and cer-
vix uteri, seminal vesicles, ovaries, epididymides, oviducts, pros-
tate, pituitary gland, coagulating gland, and any tissues with
gross lesions identiﬁed as being potentially treatment-related.
The spleen, bone marrow, thymus, representative lymph nodes
(submaxillary and mesenteric), and Peyer’s patches in the small
intestine were also examined microscopically for all control and
5% EPG animals, and any F1 satellite group in which abnormal
hematological results were noted (e.g., abnormal monocyte count).
The following tissues (when present)were examinedmicroscop-
ically for anyweaned pup that died or was sacriﬁcedmoribund, and
from selected F1b pups not assigned to satellite groups: adrenals;
aorta; brain; cecum; colon; corpus and cervix uteri; duodenum; epi-
didymides; esophagus; exorbitant lacrimal (Harderian) gland; eyes;
femur with bone marrow (articular surface of the distal end); gross
lesions; heart; ileum; jejunum; kidneys; liver (four lobes); lungs
with mainstem bronchi; lymph nodes (submaxillary and mesen-
teric); mammary gland (females); any masses; muscle (skeletal);
nasal turbinates; ovaries and oviduct; pancreas; Peyer’s patches;
pituitary; prostate; rectum; salivary gland (submaxillary); sciatic
nerve; seminal vesicles; skin; spinal cord (cervical, mid-thoracic,
and lumbar); spleen; sternum; stomach; testes; thymus; thyroid
with parathyroid; tongue; trachea; urinary bladder; uterus; vagina;
and external auditory sebaceous (Zymbal’s) gland.
2.15. Liver and serum vitamin assays
At the time of scheduled sacriﬁce, all F0 females and males, F1a
and F1b PND 4 pups and F1a and F1b satellite groups were assessed
for liver and serum fat-soluble vitamin status. Initially, only the 5%
EPG and control group animals were evaluated. When it appeared
that there might have been treatment-related differences in
vitamin levels, the decision was made to assay samples from the
remaining groups. Statistical analyses were performed to compare
EPG-exposed group values to the vehicle control group, within
sexes and times. However, because the samples for the remaining
EPG groups were analyzed at a different time, the data were
difﬁcult to reconcile.
Selected animals were bled from the abdominal vena cava and/
or via cardiac puncture to maximize blood volume and to minimize
contamination of the sample with tissue thromboplastin. The
blood was separated and at least 0.2 mL of serum was stored at
approximately 20 C until analyzed for 25-hydroxy-calciferol
(vitamin D). Vitamin K status was determined indirectly by hema-
tologic assessment of platelet count, activated partial thrombo-
plastin time and prothrombin time for all F0 animals, and F1
group B and C satellite pups. Vitamin K status was determined
indirectly by hematologic assessment of platelet count and pro-
thrombin time. F1 group A satellite pups. F1a and F1b PND 4 pups
were subjected to vitamin D analysis only. Serum 25-OH vitamin
D was analyzed by a radioimmunoassay with a commercially avail-
able kit from INCstar Corp. (Stillwater, MN).
The liver was harvested and weighed. Representative samples
from each lobe were pooled, weighed, frozen using dry ice, and
stored at 70 C until analyzed for trans-retinol (vitamin A) and a-
tocopherol (vitamin E) by HPLC employing UV spectrophotometric
detection as adapted from the method of Milne and Botnen (1986).Initially, liver and serum vitamin assays were limited to the 5%
EPG and control groups. Further analysis was performed on the
retained duplicate frozen liver samples for total vitamin A using
an extraction method which incorporated a saponiﬁcation step.
The method involved exposure of liver homogenates to 1.8 M
KOH dissolved in 50% ethanol:water at 60 C for 2 h. This step
extracts total vitamin A (both bound and free) for analysis of vita-
min content, to allow comparison of vitamin A data for this study
with vitamin A data from other studies which incorporated a
saponiﬁcation step during liver extractions.
2.16. Tissue assays for EPG
At the time of scheduled sacriﬁce, representative samples of the
liver (all lobes), kidneys, spleen, and abdominal fat (adipose tissue)
from F0 animals and pups assigned to satellite groups (control and
5% EPG groups) were collected and stored at approximately 20 C
until analyzed for EPG concentration. Tissue samples were evalu-
ated using Waters 845 HPLC (high-performance liquid chromatog-
raphy) and data systemwith a reverse phase, Beckman Ultrasphere
ODS (25 cm  4.6 mm ID), Dupont Zorbax Rx-C8 guard cartridge.
2.17. Statistical analyses
The unit of comparison was the male, the female, the pregnant
female or the litter. Quantitative continuous data (e.g., parental and
pup body weights, organ weights, food consumption, etc.) were
compared among the four treatment groups and the one vehicle
control group by the use of Bartlett’s test for homogeneity of vari-
ances (Snedecor and Cochran, 1967). Data within groups were also
evaluated for normality. If Bartlett’s test indicated lack of homoge-
neity of variances (i.e., p < 0.001) or the test for normality was
rejected for the majority of the groups, then nonparametric statis-
tical tests were employed for the continuous variables (Winer,
1962; see below). If Bartlett’s test indicated homogeneous vari-
ances (i.e., p > 0.001) and the data were normally distributed, then
the following parametric statistical tests were employed for the
continuous variables: Analysis of variance (ANOVA) was used to
determine if signiﬁcant differences were present among the groups
with Dunnett’s test for pairwise comparisons (Dunnett, 1955,
1964) to the designated control group, if the ANOVA was signiﬁ-
cant. Appropriate General Linear Models (GLM, SAS Institute, Inc.,
1989a, 1989b, 1990a, 1990b, 1990c) analyses were used to deter-
mine the signiﬁcance of the dose-response relationship (Test for
Linear Trend).
Litter-based percentage data (e.g., periodic pup survival indices)
were arcsine-square root transformed prior to statistical analysis
(Snedecor and Cochran, 1967) to allow use of parametric methods.
For the litter-based percentage data, the ANOVA was weighted
according to litter size. Nonparametric tests used for continuous
data which did not have homogeneous variances included the
Kruskal–Wallis test to determine if signiﬁcant differences were
present among the groups, followed by the Mann–Whitney U test
for pairwise comparisons to the designated control group if the
Kruskal–Wallis test was signiﬁcant (Siegel, 1956). Jonckheere’s test
for K independent samples (Jonckheere, 1954) was used to identify
signiﬁcant dose-response trends for nonparametric continuous
data. Frequency data such as reproductive indices (e.g., mating
and fertility indices) were not transformed. All indices were ana-
lyzed by Chi Square Test for Independence and Fisher’s Exact Test
for pairwise comparisons to the designated control group (with
appropriate corrections for multiple comparisons), if Chi Square
was signiﬁcant (Snedecor and Cochran, 1967). For frequency data,
the Cochran–Armitage Test for Linear Trend on proportions
(Cochran, 1954; Armitage, 1955; Agresti, 1990) was used to iden-
tify signiﬁcant dose-related linear trends for nominal data. For all
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was used as the criterion for signiﬁcance.
A test for statistical outliers (SAS) was performed on adult body
weights and feed consumption (in g/day). If examination of perti-
nent study data did not provide a plausible biologically-sound rea-
son for inclusion of the data ﬂagged as ‘‘outlier,’’ the data were
excluded from summarization and analysis and were designated
as outliers. If feed consumption data in g/kg/day were negative
for a given animal and day, they were designated ‘‘unrealistic’’
and excluded from summarization and analysis. If feed consump-
tion data for a given observational interval (e.g., GD 0–7 or PND
4–7) for a given animal were designated outliers or unrealistic,
then summarized data encompassing this period (e.g., GD 0–20
gestational period, or PND 0–21 lactational period) also did not
include this value.
A combination of categorical, analysis of variance and paramet-
ric repeated measures techniques, survival time methods, and
complex sample survey techniques for clustered or correlated data
was used in the statistical analysis of the developmental land-
marks/behavioral endpoints. The analyses were carried out using
the FREQ, GLM, NPAR1WAY, LIFETEST, and PHGLM procedures in
the SAS software package (SAS Version 6, 1990), as well as the
DESCRIPT, LOGISTIC, and SURVIVAL procedures in the SUDAAN
(Research Triangle Institute, Version 6.1, 1991) software package,
in conjunction with a set of custom-designed analysis procedures.
For dichotomous variables in which observations arise as sim-
ple random samples from experimental strata (e.g., presence/
absence of a given trait in the Functional Observational Battery),
contingency table techniques were employed to examine differ-
ences among the experimental groups. These analyses include
Pearson’s chi-square test for overall heterogeneity, followed by
individual exposed vs. control group comparisons using Fisher’s
Exact test, and the Cochran–Armitage chi-square test (Armitage,
1955) for linear trend. Pairwise comparisons also include the esti-
mation of an odds ratio (with a 95% conﬁdence interval) to quan-
tify the strength of potential toxic effects. For polychotomous
data measured on a nominal or qualitative scale (e.g., posture type),
the Pearson chi-square test was employed for heterogeneity of the
response distributions, followed by individual treated vs. control
group comparisons. In addition, the contribution of each response
level was evaluated to the total chi-square statistic.
For continuous analysis variables and count data (e.g., body
weights, rearing activity in motor activity trials), a battery of para-
metric (or non-parametric) tests was performed to compare the
experimental groups. If the assumptions for parametric analyses
were not satisﬁed (as determined by Bartlett’s test for homogene-
ity of variance and Shapiro–Wilk’s test for departure from normal-
ity), non-parametric analyses were employed. Parametric analyses
included Dunnett’s t-test for simultaneous exposed vs. control
group comparisons (p 6 0.05, 60.01, and 60.001), followed by a
linear contrast for monotonic trend. Dunnett’s test adjusted the
overall type I error rate for multiple comparisons, eliminating the
need to perform a preliminary test for overall heterogeneity. Anal-
ogously, the non-parametric analyses consisted of Fligner’s (1984)
test for simultaneous exposed vs. control group comparisons
(p < 0.05, <0.01, and <0.001), followed by the Jonckheere-Terpstra
(Jonckheere, 1954) test for trend. Again, since Fligner’s test
adjusted for multiple comparisons, the overall Kruskal–Wallis test
for heterogeneity was not considered before performing the com-
parisons of exposed groups to control. For polychotomous end-
points measured on an ordinal scale (e.g., severity scores in FOB
data), nonparametric techniques as described above were
employed.
A nested ANOVAmodel was used for analyzing continuous vari-
ables with correlated observations (e.g., through clustering of
responses within litters, as seen in the analysis of time to develop-mental landmarks). In this case, the statistical model included the
regression effect of dose and litters nested within dose, the latter
effect serving as the appropriate error term for testing the hypoth-
esis of no treatment effect against various alternatives (heteroge-
neity, linear trend). In addition, when the design was unbalanced
(e.g., an unequal number of pups per litter), a Satterthwaite
correction was applied to the usual F-test for no dose effect.
In addition to analysis of variance techniques applied at given
points in time, several behavioral variables were analyzed as
repeated measures on the animals over time, where ‘‘time’’ may
actually represent trials, blocks, or 10-min periods in a 1-h session.
Such response variables may include 10-min activity measures in a
1-h session on a given day, total activity, or time to habituation in
motor activity trials. For continuous responses measured over time
(e.g., 10-min activity levels), parametric repeated measures tech-
niques were used. The mixed analysis of variance model included
exposure level as the grouping factor (ﬁxed effect), as well as the
random effects of animals nested within exposure groups, with
repeated observations on the animals over time. Contrasts were
constructed to examine the linear, quadratic, and cubic compo-
nents of the time effect and their interaction with exposure groups.
This model is useful in analyzing linear and non-linear trends in
behavioral measures over time, as well as possible differences in
these trends among the exposure groups (Winer, 1971). Additional
covariates may also be included.
Distribution-free procedures used routinely for analyzing com-
plex sample survey data (Cochran, 1977) were employed for two
types of repeated measures data: dichotomous or incidence data
(yes/no responses) and censored time-to-event data. Unlike the
parametric procedures, the survey data techniques make no
distributional assumptions concerning the response of interest
(i.e., multivariate normality) or the correlations among repeated
observations (i.e., compound symmetry), thereby providing
ﬂexibility for a variety of analytical settings. Consistent variance
estimators for sample statistics (means, proportions, ratios, regres-
sion coefﬁcients) are provided by applications of ﬁrst-order Taylor
series approximations in accordance with the hierarchical
sampling design (Binder, 1993, 1992). Both descriptive statistics
capabilities (e.g., means, medians and their standard errors) and
modeling facilities (for linear, logistic, loglinear, and proportional
hazards regression) are provided in SUDAAN. Estimated design
effects (or the ratio of the variance estimates for the clustered
design vs. a simple random sample of independent observations)
were provided for all sample statistics.
For variables whichmeasure the time to some event on observa-
tions that are statistically independent (i.e., not related through lit-
ters or repeated observations over time), standard survival
analysis techniques were applied. One such example was the habit-
uation onset time inmotor activity trials (if repeatedmeasures over
days are not of concern). The logrank test (Cox, 1972;Mantel, 1966)
and Tarone’s (1975) test was employed to compare the event time
distributions in the experimental groups. The Cox proportional haz-
ardsmodel (Cox, 1972) can be used to incorporate additional covar-
iates, such as sex, if necessary. These techniques, which utilize the
actual time to the event, are sensitive to differences in the overall
incidence rates as well as the distribution of onset times for the
event. Kaplan and Meier (1958) survival curves were used to
describe the proportion of animals in each exposure group having
not reached the speciﬁed event over the course of time. Non-over-
lapping survival time distributions indicate differences in median
event times among the experimental groups. Speciﬁcally, the log
rank test was used to detect overall heterogeneity in event time dis-
tributions among the experimental groups, as well as to perform
individual pairwise comparisons of exposed groups to control. Tar-
one’s test was employed to detect a dose-related trend in onset
times. Median event times and censoring rates were provided.
Table 4
Survival of F0 females.
EPG in diet (g/kg bw/day) 5%
0 0.5 1 2
Number started on study 30 30 30 30 30
Deaths
Prebreeding 0 0 0 0 0
1st mating period 0 0 0 0 0
Gestation of F1a litter 1a 0 1b 2b 1b
Lactation of F1a litter 1a 0 1a 0 0
Holding period (before 2nd mating) 0 0 1b 0 0
2nd mating period 0 0 0 0 0
Gestation of F1b litter 0 0 0 1b 0
Lactation of F1b litter 0 1a 0 0 1b
Holding period (before scheduled sacriﬁce) 0 2c 1c 1b 0
Scheduled sacriﬁce 28 27 26 26 28
a Sacriﬁced moribund.
b Found dead.
c Died during orbital bleeding.
Table 5
Mean EPG intakes (g/kg bw/day) among F0 females.
Period EPG in diet (g/kg bw/day) 5%
0.5 1 2
Prebreeding 0.39 0.80 1.38 3.99 (range: 1.39–6.96)
Gestation [F1a] 0.57 1.06 2.19 2.98 (range: 2.44–4.11)
Lactation* [F1a] 0.84 1.43 3.24 4.30 (range: 2.99–5.42)
PND 0–4
PND 4–7 1.20 1.89 4.42 6.02 (range: 4.51–7.67)
PND 7–14 1.55 2.71 5.62 8.10 (range: 6.30–9.72)
Gestation [F1b] 0.54 1.00 2.02 2.79 (range: 2–3.82)
Lactation* [F1b] 0.69 1.31 2.88 3.37 (range: 1.91–4.89)
PND 0–4
PND 4–7 1.05 1.93 3.90 5.20 (range: 3.45–6.32)
PND 7–14 1.39 2.50 5.37 6.90 (range: 3.75–8.33)
PND: postnatal day.
Note: EPG intake of during mating was not calculated because male vs. female feed
intake could not be determined when they were housed together.
* EPG intakes during lactation exceeded the targeted amounts due to two factors:
(1) dams typically consume more feed during lactation to fuel milk production,
especially during the ﬁrst 2 weeks when milk production is highest (i.e., increased
feed intake without signiﬁcant body weight change); and (2) pups begin to self-feed
during the second week after birth, so that ‘‘maternal’’ feed consumption actually
represents feed consumption for the ‘‘maternal-litter’’ unit from PND 10 for the last
half of lactation. This latter confounder is why maternal feed consumption data
were only collected for PND 0–14, and why the dietary levels of EPG were reduced
by half in the formulated diets to preclude or minimize any possible overexposure
of the feeding pups.
Table 6
Mean EPG intakes (g/kg bw/day) among F0 males.
Period EPG in diet 5%
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3.1. Mortality and clinical signs
The fate of F0 males and females is summarized in Tables 3 and
4, respectively. A total of seven males and females died prior to
scheduled sacriﬁce; most were found dead. None of the deaths
appeared to be related to EPG.
Clinical observations were limited to occasional ﬁndings in all
groups of alopecia, skin sores, and injuries to eyes from retro-
orbital bleeding trauma. Alopecia is a common ﬁnding in rats in
long-term housing; the sores, predominantly on the back, head
and shoulders, were likely caused by rubbing against the edge of
the feed jar lids.
3.2. Body weights, feed consumption, and EPG intake
No biologically relevant differences among groups for mean
weekly body weights, or mean weekly body weight changes were
observed. Feed consumption, in g/day or g/kg/day, also did not
differ among groups. Statistically signiﬁcant differences were
observed occasionally, but with no apparent relationship to EPG.
Mean EPG intakes among F0 females, F0 males, and F1 (weaned)
pups are summarized in Tables 5–7, respectively. The adjusted
diets in groups receiving 0.5, 1, and 2 g/kg/day of EPG resulted in
intakes slightly below target values during the prebreed phase;
intakes increased thereafter. Animals receiving a ﬁxed intake of
5% EPG in the diet had the expected decrease in EPG intake over
time; the result of feed consumption in g/day remaining relatively
constant and the mean body weights increasing markedly over
time so that mean feed intake in g/kg/day decreased markedly over
time.
EPG intakes were at or above target values during the gesta-
tional and lactational periods. Maternal lactational EPG intake
exhibited the expected increases across groups for all intervals
evaluated (PND 0–4, 4–7 and 7–14). As would be expected, EPG
intakes among the 0.5, 1, and 2 g/kg bw/day groups exceeded
target values during lactation.
3.3. Reproductive and offspring parameters
Tables 8 and 9 summarize reproductive and offspring parame-
ters for the each of the two consecutive litters. There were no sta-
tistically signiﬁcant differences among groups, except for the
percent F1b male pups per litter, which was lower for the 1 and
2 g/kg bw/day EPG groups, compared to control. There were two
females from the 5% EPG group whose pregnancy (as resorption
sites) was evident only after necropsy. The data from these animals
were not included in the summary tables, since the time of preg-
nancy, i.e., the F1a or F1b mating, could not be established.Table 3
Survival of F0 males.
EPG in diet (g/kg bw/day) 5%
0 0.5 1 2
Number started on study 30 30 30 30 30
Deaths
Prebreeding 0 0 0 1a 1b
1st mating period 0 0 0 0 0
Holding period (before 2nd mating) 0 0 0 0 0
2nd mating period 0 0 0 0 0
Holding period (before scheduled sacriﬁce) 2a,b 1b 2a,b 0 0
Scheduled sacriﬁce 28 29 28 29 29
a Died during orbital bleeding.
b Found dead.
(g/kg bw/day)
0.5 1 2
Prebreeding 0.4 0.81 1.61 3.12 (range: 1.31–5.59)
Holding period 1
(before 2nd mating)
0.48 0.98 1.90 2.02 (range: 1.64–2.71)
Holding period 2
(before scheduled sacriﬁce)
0.44 0.89 1.74 1.83 (range: 1.43–2.33)3.4. Hematology and clinical chemistry
Some statistically signiﬁcant differences were observed
between the control and EPG groups in hematology and clinical
chemistry parameters. However, none was associated with histo-
pathological changes or other clinical manifestation.
Table 7
Range of mean EPG intakes (g/kg bw/day) among pups after weaning.
Litter/sex EPG in diet (g/kg bw/day) 5%
0.5 1 2
F1a (B) # PND 21–49 0.23–0.37 0.48–0.70 0.89–1.46 4.62–6.82
F1a (B) $ PND 21–49 0.21–0.36 0.46–0.70 0.92–1.40 4.61–6.53
F1a (C) # PND 21–91 0.22–0.46 0.46–0.95 0.89–1.75 2.64–6.64
F1a (C)$ PND 21–91 0.24–0.56 0.46–1.05 0.95–2.22 3.98–6.41
F1b (B) # PND 21–49 0.23–0.39 0.47–0.71 0.87–1.51 4.73–6.52
F1b (B) $ PND 21–49 0.21–0.43 0.46–0.76 0.90–1.70 5.15–6.62
F1b (C) # PND 21–91 0.24–0.46 0.46–0.88 0.86–1.93 2.57–6.60
F1b (C)$ PND 21–91 0.23–0.52 0.47–0.96 0.88–2.26 3.51–6.67
PND: postnatal day.
Table 8
Mean values for reproductive (F0) and offspring (F1a litter) indices.
EPG in diet (g/kg bw/day) 5%
0 0.5 1 2
# Males started on study 30 30 30 30 30
# Males paired 30 30 30 29 29
# Males mated 29 29 26 26 25
# Males siring litters 24 24 22 21 20
Male fertility index 82.8% 82.8% 84.6% 80.8% 80%
# Females started on study 30 30 30 30 30
# Females paired 30 30 30 30 30
# Females mated 29 29 26 28 27
# Pregnant 24 24 22 22 21
Female fertility index 82.8 82.8 84.6 78.6 77.8
# Females with live litters 23 23 22 21 20
Gestational index 100% 95.8% 100% 100% 95.2%
Pregnancy index 82.8% 82.8% 84.6% 84.6% 84%
Time to insemination# (days) 4.4 4.4 3.3 4 5.1
Gestational length# (days) 22.3 22.5 22.5 22.4 22.6
# Live pups at birth# (PND 0) 14.6 13.5 14 13.6 14.3
# Dead pups at birth# (PND 0) 0.7 0.7 1.8 0.3 0.3
# Pups born# (PND 0) 15.3 14.2 15.7 13.9 14.5
Stillbirth index# 4.5% 6.3% 13.9% 1.6% 5.5%
Live birth index# 95.5% 93.7% 86.1% 98.4% 94.5%
4-Day survival index# 95.3% 98.1% 90.7% 97.5% 93.8%
7-Day survival index# 94.5% 99.6% 91.6% 98.5% 100%
14-Day survival index# 99.5% 100% 99.4% 99% 100%
21-Day survival index# 100% 100% 100% 100% 100%
Lactational index# 94.1% 99.6% 91.1% 97.5% 100%
PND 0 (birth)
# Live litters 23 23 21 20 19
# Pups per litter 14.6 14 14 13.6 15
Pup body weight** (g) 6.6 6.43 5.98 6.61 6.46
Male pup body weight** (g) 6.75 6.63 6.13 6.74 6.56
Female pup body weight* (g) 6.43 6.22 5.80 6.47 6.25
% Male pups per litter 52.4 50.1 49.7 51.8 50.5
PND 4
# Live litters 22 23 19 20 18
# Pups per litter 13.8 13.8 13.6 13.3 14.8
Pup body weight** (g) 11.25 11.32 9.49 11.66 11.22
Male pup body weight*** (g) 11.44 11.59 9.83 11.87 11.32
Female pup body weight* (g) 11.06 10.99 9.36 11.40 10.89
% Male pups per litter 52.2 49.9 49.5 51.5 47.7
PND 7
# Live litters 21 23 18 20 18
# Pups per litter 9.5 9.9 8.8 8.8 9.7
Pup body weight*** (g) 18.89 18.05 15.94 18.81 18.53
Male pup body weight*** (g) 19.13 18.53 16.43 19.27 18.87
Female pup body weight*** (g) 18.58 17.54 15.34 18.52 17.87
% Male pups per litter 50 50 51.9 51.1 47.9
PND 14
# Live litters 21 23 18 20 18
# Pups per litter 9.9 9.9 9.2 8.7 9.7
Pup body weight*** (g) 38.64 36.93 35.67 40.41 38.67
Male pup body weight** (g) 39.14 37.8 36.58 41.21 39.08
Female pup body weight** (g) 38.05 36.04 34.78 39.9 37.77
% Male pups per litter 50.3 49.6 50.9 51.1 47.9
PND 21
# Live litters 21 23 18 20 18
# Pups per litter 9.9 9.9 9.2 8.7 9.7
Pup body weight* (g) 59.33 56.92 55.54 62.11 59.28
Male pup body weight* (g) 60.36 58.34 57.59 63.69 60.02
Female pup body weight* (g) 58.10 55.51 53.54 60.68 57.59
% Male pups per litter 50.3 49.6 50.9 51.1 47.9
PND: postnatal day
 Includes one female that was pregnant but did not deliver a live litter.
# Bartlett’s test for homogeneity of variances was signiﬁcant (p < 0.001) or could
not be done because there was zero variance in one or more groups and/or the test
for normality was rejected (p < 0.05) for the majority of the groups, therefore
nonparametric statistical tests were employed for evaluation of the data.
* p 6 0.05, ANOVA; follow-up pairwise comparison showed no statistical
signiﬁcance.
** p 6 0.01, ANOVA; follow-up pairwise comparison showed no statistical
signiﬁcance.
*** p 6 0.001, ANOVA; follow-up pairwise comparison showed no statistical
signiﬁcance.
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had signiﬁcantly greater A/G ratios; for the F0 the difference was
evident at prebreeding (after EPG treatment started but before ﬁrst
mating) and at necropsy. There were also trends toward greater
A/G ratios in these groups and in the F1a(C) and F1b(A)-1 satellite
group males. In at least the F0 males (at necropsy), the effect might
have been related to higher albumin levels, which showed a statis-
tically signiﬁcant trend (increase) across EPG groups.
Other effects that reached statistical signiﬁcance were not con-
sistent across groups and/or did not appear to be related to EPG
concentration. Corrected white blood cells counts, for example,
were greater than control in F1a(A)-1 females at 0.5 g/kg bw/day
and F1a(B) females at 1 g, showed a signiﬁcant upward trend in
F0 females at necropsy, but were lower in F1a(C) males exposed
to 2 g/kg bw/day or 5% EPG. Similar inconsistently higher or lower
values were observed for PT, APTT, platelets, and monocytes. Total
protein levels were lower than control in F1a(B) females exposed to
2 g/kg bw/day or 5% EPG; there were also trends toward lower
total protein levels in F1a(B) females and F1b(C) males.
3.5. Developmental landmarks
Some statistically signiﬁcant differences in developmental land-
marks were observed, but with no evidence of a relationship to
EPG concentration. In particular, statistically signiﬁcant differences
from the control group were limited to the following: (1) the aver-
age day of pinna detachment was greater for F1a females in the 1 g/
kg/day EPG group, with no signiﬁcant pairwise differences or
trends noted for acquisition of this landmark among F1a males,
F1b females or F1b males; (2) the average day for lower incisor erup-
tion was greater for F1a males in the 1 g/kg/day EPG group and
lower for F1b males in the 0.5 g/kg/day EPG group; (3) eye opening
occurred later for F1a pups in the 1 g/kg/day EPG group and earlier
for F1a females in the 5% EPG group; (4) average day of testes des-
cent exhibited an increasing trend in the F1a litters, possibly related
to a low control group value for the F1a litters (PND 23.2 vs. PND
25.20 for F1b controls).
3.6. Functional observational battery and motor activity
Some statistically signiﬁcant differences in the functional
observational battery (FOB) and motor activity testing were
observed. However, since none showed consistency across groups
(i.e., offspring from both matings) or time period, the differences
were considered unrelated to EPG treatment.
3.7. Necropsy and histopathological ﬁndings
For the F0 generation, gross lesions were sporadic, occurring in a
single animal, with equal frequency between the control and EPG
groups, and/or with no apparent relationship to EPG concentration.
Table 9
Mean values for reproductive (F0) and offspring (F1b litter) indices.
EPG in diet (g/kg bw/day) 5%
0 0.5 1 2
# Males started on study 30 30 30 30 30
# Males paired 30 30 30 29 29
# Males mated 24 23 21 20 23
# Males siring litters 20 19 16 16 21
Male fertility index 83.3% 82.6% 76.2% 80% 91.3%
# Females started on study 30 30 30 30 30
# Females paired 28 30 27 28 29
# Females mated 24 24 21 21 24
# Pregnant 20 20 16 16 21
Female fertility index 83.3% 83.3% 76.2% 76.2% 87.5%
# Females with live litters 20 20 15 16 21
Gestational index 100% 100% 93.8% 100% 100%
Pregnancy index 83.3% 87% 76.2% 80% 91.3%
Time to insemination# (days) 2.9 3.3 4.6 7.2 6.5
Gestational length# (days) 22.3 22.5 22.4 22.5 22.4
# Live pups at birth# (PND 0) 14.6 15.1 12.4 14.5 12.7
# Dead pups at birth# (PND 0) 0.4 0.5 0.8 0.1 1
# Pups born (PND 0) 15 15.5 13.2 14.5 13.7
Stillbirth index# 1.9% 3% 8% 0.6% 8.1%
Live birth index# 98.1% 97% 92% 99.4% 91.9%
4-Day survival index# 94.7% 97.1% 99.6% 94.5% 88.9%
7-Day survival index# 94.5% 98.9% 99.3% 95.3% 99.4%
14-Day survival index# 100% 100% 100% 93.3% 100%
21-Day survival index# 100% 99.5% 100% 100% 100%
Lactational index# 94.5% 98.4% 99.3% 88.7% 99.4%
PND 0 (birth)
# Live litters 20 20 15 16 21
# Pups per litter# 14.6 15.1 13.3 14.5 12.7
Pup body weight# (g) 6.62 6.58 6.48 6.60 6.68
Male pup body weight# (g) 6.81 6.77 6.66 6.75 6.88
Female pup body weight (g) 6.36 6.33 6.30 6.41 6.34
% Male pups per litter#,, 57.5 55.2 40.2§§ 45§ 51.8
PND 4
# Live litters 20 20 15 15 18
# Pups per litter# 13.7 14.5 13.2 13.9 12
Pup body weight (g) 10.81 11.14 10.83 10.81 12.22
Male pup body weight (g) 11.48 11.39 11.23 11.39 12.56
Female pup body weight (g) 10.48 10.8 10.64 10.6 11.67
% Male pups per litter#, 54.2 57.3 40§ 42.4§ 54.5
PND 7
# Live litters 19 19 15 15 18
# Pups per litter# 9.1 9.5 8.9 8.5 8.8
Pup body weight (g) 18.92 18.51 17.19 18.52 19.81
Male pup body weight (g) 19.27 18.96 18.14 19.17 20.05
Female pup body weight (g) 18.56 18.02 16.76 18.35 19.26
% Male pups per litter#, 51.8 50.4 41.2§§ 40.5§§ 54.8
PND 14
# Live litters 19 19 15 14 18
# Pups per litter# 9.5 9.5 8.9 8.4 8.8
Pup body weight (g) 38.58 37.49 34.97 40.43 40.52
Male pup body weight (g) 39.24 38.2 37.33 39.93 41.1
Female pup body weight (g) 37.87 36.73 34.31 40.02 39.48
% Male pups per litter# 51.8 50.4 41.2§§ 43.4§ 54.8
PND 21
# Live litters 19 19 15 14 18
# Pups per litter# 9.5 9.5 8.9 9 8.8
Pup body weight# (g) 62.38 61.26 57.3 64.86 65.66
Male pup body weight (g) 63.62 62.88 60.9 63.75 67.03
Female pup body weight# (g) 61 59.59 55.94 63.94 63.17
% Male pups per litter# 51.8 50.7 41.2§§ 43.4§ 54.8
PND: postnatal day
# Bartlett’s test for homogeneity of variances was signiﬁcant (p < 0.001) or could
not be done because there was zero variance in one or more groups and/or the test
for normality was rejected (p < 0.05) for the majority of the groups, therefore non
parametric statistical tests were employed for evaluation of the data.
 p 6 0.01, Kruskal–Wallis test.
 p < 0.05, Jonckheere’s test.
§ p 6 0.05, Mann–Whitney U test.
§§ p 6 0.01, Mann–Whitney U test.
Table 10
Summary of results for vitamin analyses.
Rats EPG in Diet (g/kg bw/day) 5%
0 0.5 1 2
Serum vitamin D
F1a PND 4 Ø Ø Ø Ø Ø
F1a(A) PND 21 Ø ; m,f ; f ; m,f ; f
F1a(B) PND 49 Ø Ø " m,f " m Ø
F1a(C) PND 91 Ø Ø " m Ø Ø
F1b PND 4 Ø Ø Ø Ø Ø
F1b(A) PND 21 Ø Ø Ø Ø Ø
F1b(B) PND 49 Ø Ø Ø Ø ; f
F1b(C) PND 91 Ø Ø Ø Ø Ø
F0 Ø ; f ; f ; f ; f
Liver vitamin E
F1a PND 4 Ø Ø Ø Ø Ø
F1a(A) PND 21 Ø Ø Ø ; f ; f
F1a(B) PND 49 Ø ; m,f ; f ; m,f ; m,f
F1a(C) PND 91 Ø ; m,f ; m,f ; m,f ; m,f
F1b PND 4 Ø Ø Ø ; m Ø
F1b(A) PND 21 Ø Ø Ø Ø ; f
F1b(B) PND 49 Ø ; m,f ; m,f ; m,f Ø
F1b(C) PND 91 Ø ; m,f ; m,f ; m,f Ø
F0 Ø Ø Ø ; m Ø
Liver vitamin A (initial assay)
F1a PND 4 Ø Ø Ø Ø Ø
F1a(A) PND 21 Ø Ø Ø Ø Ø
F1a(B) PND 49 Ø ; m,f ; m,f ; m,f Ø
F1a(C) PND 91 Ø ; m,f ; m,f ; m,f ; f
F1b PND 4 Ø Ø Ø Ø Ø
F1b(A) PND 21 Ø Ø Ø Ø Ø
F1b(B) PND 49 Ø ; f ; m,f Ø Ø
F1b(C) PND 91 Ø ; m,f ; m,f ; m,f ; f
F0 Ø ; f ; m,f ; m,f ; f
Liver vitamin A (reanalysis)
F1a PND 4 Ø Ø Ø Ø Ø
F1a(A) PND 21 Ø Ø Ø Ø Ø
F1a(B) PND 49 Ø Ø " f Ø ; m,f
F1a(C) PND 91 Ø Ø Ø Ø Ø
F1b PND 4 Ø Ø Ø Ø Ø
F1b(A) PND 21 Ø Ø Ø Ø Ø
F1b(B) PND 49 Ø Ø Ø ; m ; m,f
F1b(C) PND 91 Ø Ø Ø Ø Ø
F0 Ø ; f ; f ; m,f ; f
m = male; f = female
Ø = no statistically signiﬁcant difference vs. control
" = signiﬁcantly higher than control group value
; = signiﬁcantly lower than control group value
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ences, except for mineralization in Peyer’s patches, which occurred
in 1/30 control males vs. 5/30 males from the 5% EPG group. No sig-
niﬁcant differences in organ weights were noted, except for lower
(p < 0.01) relative liver weights among males from the 2 g/kg bw/
day group (vs. control), and greater thymus weights among F0
females receiving EPG at 1 g/kg bw/day (p < 0.01) or 2 g/kg bw/
day (p < 0.05).
For F1a and F1b pups that died during lactation (PND 0–21), nec-
ropsy ﬁndings across all groups consisted predominantly of patent
(open) ductus arteriosus, no air in the lungs, empty stomach, (the
pup had not yet nursed), autolysis, and cannibalization by the
mother. None of the ﬁndings could be attributed to EPG exposure.
F1a (B and C satellite group) pups exposed to EPG exhibited
trends toward lower relative kidney weights (relative and/or abso-
lute), but signiﬁcantly (p < 0.05) lower values (vs. control) were
seen only for male F1a(B) pups exposed to 5% EPG. Similar trends
toward lower liver weights were observed in F1a(C) pups (signiﬁ-
cant for 2 g/kg bw/day group); however, for F1b males there was
a trend toward greater absolute (but not relative) liver weights.
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The results of the analyses for the fat-soluble vitamins, serum
vitamin D and liver vitamins A and E are summarized in Table 10.
Serum vitamin D levels were lower in all F0 females (but not F0
males) receiving EPG and in F1a(A) PND 21 female offspring. EPG
exposure was also associated with signiﬁcantly lower liver vitamin
E levels in male and female offspring.
An initial analysis showed signiﬁcantly lower liver vitamin A in
F0 females and offspring (male and female) across all EPG groups;
in F0 males, lower liver vitamin A levels were seen only at 1 and
2 g/kg bw/day. Reanalysis of liver vitamin A using a saponiﬁcation
step showed: lower levels in F1a(B) and F1a(C) pups (at PND 49) of
both sexes exposed to 5% EPG; higher levels in F1a(B) female pups
exposed to 1 g/kg bw/day; and lower levels in F1b(B) males
exposed to 2 g/kg bw/day.
3.9. Tissue EPG assays
EPG was not detected in any liver sample analyzed (354 total
from the control and 5% EPG groups). Analysis of other tissues
(including some control samples) showed positive results for the
presence of EPG. The results were considered artifactual, since they
could not be attributed to contamination during necropsy or anal-
ysis, were evenly divided between the control and 5% EPG groups,
and were not associated with other measures indicative of in vivo
systemic exposure (e.g., EPG in liver, ﬁrst site after presumed intes-
tinal absorption, which did not occur). In particular, EPG was
detected in: 2/354 kidney samples (1 each at 0% and 5% EPG); 7/
354 spleen samples (4 at 0% and 3 at 5% EPG); and 2/334 adipose
samples (at 5% EPG).
4. Discussion
Continuous exposure to EPG up to 5% in the diet for 13 weeks of
prebreed and through two breeding cycles for F0 parental animals,
and through PND 91 for F1a and F1b offspring, resulted in no consis-
tent indications of reproductive or systemic toxicity. No consistent
treatment-related effects were observed in F0, F1a or F1b body
weights, weight gains, feed consumption, clinical observations,
mating indices, survival, growth and development of F1a and F1b lit-
ters, including litter sizes, body weights, sex ratios (except for
lower percent F1b male pups per litter at 1 and 2 g/kg bw/day of
EPG), acquisition of developmental landmarks, behavioral indices
in FOB and motor activity, or histology of selected organs.
In some groups, EPG was associated with lower serum vitamin
D, liver vitamin A, and liver vitamin E. F0 females were more
severely affected for vitamins D and A, perhaps due to the
increased demands from the pregnancies. However, none of the
reductions were associated with other apparent consequences
and were not judged to be biologically signiﬁcant. In other exper-
imental animal studies, EPG has been shown to have an effect on
lipid-soluble vitamins (unpublished data). It is therefore possible
that, as a nondigestible lipid-like substance, it acts as a lipid ‘‘sink’’
or additional ‘‘compartment’’ for the distribution of lipid-soluble
substances, including fat-soluble vitamins present in the gut
lumen. Other studies in rats and mice (data not presented)
conﬁrmed an absence of any indications of vitamin deﬁciencies
following lifetime exposures.Hematology and clinical chemistry showed greater (and/or
trends toward greater) serum A/G (albumin to globulin) ratios in
males receiving 2 g/kg bw/day and 5% of EPG. The biological signif-
icance of greater A/G ratios, if any, is doubtful, especially since the
effect was not seen in all groups of males or in females.
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